Literature DB >> 28263292

The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology.

Akinori Kawakami1, David E Fisher1.   

Abstract

Certain transcription factors have vital roles in lineage development, including specification of cell types and control of differentiation. Microphthalmia-associated transcription factor (MITF) is a key transcription factor for melanocyte development and differentiation. MITF regulates expression of numerous pigmentation genes to promote melanocyte differentiation, as well as fundamental genes for maintaining cell homeostasis, including genes encoding proteins involved in apoptosis (eg, BCL2) and the cell cycle (eg, CDK2). Loss-of-function mutations of MITF cause Waardenburg syndrome type IIA, whose phenotypes include depigmentation due to melanocyte loss, whereas amplification or specific mutation of MITF can be an oncogenic event that is seen in a subset of familial or sporadic melanomas. In this article, we review basic features of MITF biological function and highlight key unresolved questions regarding this remarkable transcription factor.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28263292     DOI: 10.1038/labinvest.2017.9

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  95 in total

1.  Sumoylation of MITF and its related family members TFE3 and TFEB.

Authors:  Arlo J Miller; Carmit Levy; Ian J Davis; Ehud Razin; David E Fisher
Journal:  J Biol Chem       Date:  2004-10-25       Impact factor: 5.157

2.  Genomic analysis of the Microphthalmia locus and identification of the MITF-J/Mitf-J isoform.

Authors:  Christine L Hershey; David E Fisher
Journal:  Gene       Date:  2005-02-28       Impact factor: 3.688

3.  Regulation of MITF stability by the USP13 deubiquitinase.

Authors:  Xiansi Zhao; Brian Fiske; Akinori Kawakami; Juying Li; David E Fisher
Journal:  Nat Commun       Date:  2011-08-02       Impact factor: 14.919

4.  A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.

Authors:  Corine Bertolotto; Fabienne Lesueur; Sandy Giuliano; Thomas Strub; Mahaut de Lichy; Karine Bille; Philippe Dessen; Benoit d'Hayer; Hamida Mohamdi; Audrey Remenieras; Eve Maubec; Arnaud de la Fouchardière; Vincent Molinié; Pierre Vabres; Stéphane Dalle; Nicolas Poulalhon; Tanguy Martin-Denavit; Luc Thomas; Pascale Andry-Benzaquen; Nicolas Dupin; Françoise Boitier; Annick Rossi; Jean-Luc Perrot; Bruno Labeille; Caroline Robert; Bernard Escudier; Olivier Caron; Laurence Brugières; Simon Saule; Betty Gardie; Sophie Gad; Stéphane Richard; Jérôme Couturier; Bin Tean Teh; Paola Ghiorzo; Lorenza Pastorino; Susana Puig; Celia Badenas; Hakan Olsson; Christian Ingvar; Etienne Rouleau; Rosette Lidereau; Philippe Bahadoran; Philippe Vielh; Eve Corda; Hélène Blanché; Diana Zelenika; Pilar Galan; François Aubin; Bertrand Bachollet; Céline Becuwe; Pascaline Berthet; Yves Jean Bignon; Valérie Bonadona; Jean-Louis Bonafe; Marie-Noëlle Bonnet-Dupeyron; Fréderic Cambazard; Jacqueline Chevrant-Breton; Isabelle Coupier; Sophie Dalac; Liliane Demange; Michel d'Incan; Catherine Dugast; Laurence Faivre; Lynda Vincent-Fétita; Marion Gauthier-Villars; Brigitte Gilbert; Florent Grange; Jean-Jacques Grob; Philippe Humbert; Nicolas Janin; Pascal Joly; Delphine Kerob; Christine Lasset; Dominique Leroux; Julien Levang; Jean-Marc Limacher; Cristina Livideanu; Michel Longy; Alain Lortholary; Dominique Stoppa-Lyonnet; Sandrine Mansard; Ludovic Mansuy; Karine Marrou; Christine Matéus; Christine Maugard; Nicolas Meyer; Catherine Nogues; Pierre Souteyrand; Laurence Venat-Bouvet; Hélène Zattara; Valérie Chaudru; Gilbert M Lenoir; Mark Lathrop; Irwin Davidson; Marie-Françoise Avril; Florence Demenais; Robert Ballotti; Brigitte Bressac-de Paillerets
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

5.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease.

Authors:  V Pingault; N Bondurand; K Kuhlbrodt; D E Goerich; M O Préhu; A Puliti; B Herbarth; I Hermans-Borgmeyer; E Legius; G Matthijs; J Amiel; S Lyonnet; I Ceccherini; G Romeo; J C Smith; A P Read; M Wegner; M Goossens
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

6.  The transcription factor onecut-2 controls the microphthalmia-associated transcription factor gene.

Authors:  P Jacquemin; V J Lannoy; J O'Sullivan; A Read; F P Lemaigre; G G Rousseau
Journal:  Biochem Biophys Res Commun       Date:  2001-08-03       Impact factor: 3.575

7.  microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.

Authors:  T J Hemesath; E Steingrímsson; G McGill; M J Hansen; J Vaught; C A Hodgkinson; H Arnheiter; N G Copeland; N A Jenkins; D E Fisher
Journal:  Genes Dev       Date:  1994-11-15       Impact factor: 11.361

8.  alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome.

Authors:  E R Price; M A Horstmann; A G Wells; K N Weilbaecher; C M Takemoto; M W Landis; D E Fisher
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

9.  Interactions of Melanoma Cells with Distal Keratinocytes Trigger Metastasis via Notch Signaling Inhibition of MITF.

Authors:  Tamar Golan; Arielle R Messer; Aya Amitai-Lange; Ze'ev Melamed; Reut Ohana; Rachel E Bell; Oxana Kapitansky; Galya Lerman; Shoshana Greenberger; Mehdi Khaled; Nira Amar; Jean Albrengues; Cedric Gaggioli; Pinchas Gonen; Yuval Tabach; David Sprinzak; Ruby Shalom-Feuerstein; Carmit Levy
Journal:  Mol Cell       Date:  2015-07-30       Impact factor: 17.970

10.  Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy.

Authors:  Michael P Smith; Holly Brunton; Emily J Rowling; Jennifer Ferguson; Imanol Arozarena; Zsofia Miskolczi; Jessica L Lee; Maria R Girotti; Richard Marais; Mitchell P Levesque; Reinhard Dummer; Dennie T Frederick; Keith T Flaherty; Zachary A Cooper; Jennifer A Wargo; Claudia Wellbrock
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 38.585

View more
  66 in total

1.  Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia.

Authors:  Alessia Oppezzo; Julie Bourseguin; Emilie Renaud; Patrycja Pawlikowska; Filippo Rosselli
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

2.  Antimelanoma activity of perphenazine and prochlorperazine in human COLO829 and C32 cell lines.

Authors:  Michał Otręba; Monika Pajor; Jared D Warncke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-06       Impact factor: 3.000

3.  Translation regulation in skin cancer from a tRNA point of view.

Authors:  Katerina Grafanaki; Dimitrios Anastasakis; George Kyriakopoulos; Ilias Skeparnias; Sophia Georgiou; Constantinos Stathopoulos
Journal:  Epigenomics       Date:  2018-12-19       Impact factor: 4.778

4.  STIM1 (c)AMPs up melanogenesis.

Authors:  Jonathan Soboloff; Bojana Gligorijevic; M Raza Zaidi
Journal:  EMBO J       Date:  2018-02-15       Impact factor: 11.598

5.  Altered Notch Signaling in Dowling-Degos Disease: Additional Mutations in POGLUT1 and Further Insights into Disease Pathogenesis.

Authors:  Damian J Ralser; Hideyuki Takeuchi; Günter Fritz; F Buket Basmanav; Maike Effern; Sugirthan Sivalingam; Laila El-Shabrawi-Caelen; Ece N Degirmentepe; Emek Kocatürk; Manuraj Singh; Nina Booken; Natalia M K Spierings; Viktor Schnabel; Andre Heineke; Jana Knuever; Sabrina Wolf; Maria Wehner; Michael Tronnier; Martin Leverkus; Iliana Tantcheva-Poór; Jörg Wenzel; Vinzenz Oji; Cristina Has; Michael Hölzel; Jorge Frank; Robert S Haltiwanger; Regina C Betz
Journal:  J Invest Dermatol       Date:  2018-11-09       Impact factor: 8.551

Review 6.  EGR-mediated control of STIM expression and function.

Authors:  Christina K Go; Scott Gross; Robert Hooper; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2018-12-06       Impact factor: 6.817

7.  BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.

Authors:  Matthew G Field; Jeffim N Kuznetsov; Parker L Bussies; Louie Z Cai; Karam A Alawa; Christina L Decatur; Stefan Kurtenbach; J William Harbour
Journal:  Clin Cancer Res       Date:  2019-07-08       Impact factor: 12.531

8.  Investigating Cellular Trajectories in the Severity of COVID-19 and Their Transcriptional Programs Using Machine Learning Approaches.

Authors:  Hyun-Hwan Jeong; Johnathan Jia; Yulin Dai; Lukas M Simon; Zhongming Zhao
Journal:  Genes (Basel)       Date:  2021-04-24       Impact factor: 4.096

9.  Melanocyte progenitor cells reside in human subcutaneous adipose tissue.

Authors:  Yuri Ikeda; Akino Wada; Toshio Hasegawa; Mutsumi Yokota; Masato Koike; Shigaku Ikeda
Journal:  PLoS One       Date:  2021-08-25       Impact factor: 3.240

10.  Expanding the phenotype of E318K (c.952G > A) MITF germline mutation carriers: case series and review of the literature.

Authors:  Leandro Jonata Carvalho Oliveira; Aline Bobato Lara Gongora; Fabiola Ambrosio Silveira Lima; Felipe Sales Nogueira Amorim Canedo; Carla Vanessa Quirino; Janina Pontes Pisani; Maria Isabel Achatz; Benedito Mauro Rossi
Journal:  Hered Cancer Clin Pract       Date:  2021-07-21       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.